OOOlusegun Michael Otunuga

Olusegun Michael Otunuga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olusegun Michael Otunuga has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • From Outbreak to Endemicity or Control: Tracking First Passage Time in Infectious Diseases

    by Olusegun Michael Otunuga

    This study investigates the transition from outbreak to endemic states or endemic control by analyzing the effective reproduction number R(t) within a stochastic epidemic framework. We derive the transition and stationary probability density functions of R(t), which are then used to characterize the first passage time (FPT) of R(t) across a boundary Z. These are later used to calculate the distribution of the first time that infection will dominate (or be controlled) in a population. Analytical expressions for some properties of the distribution provide quantitative measures of when endemic transition is likely to emerge under stochastic fluctuations. For a fixed threshold Z, the crossing time marks the moment R(t) first signals sustained endemic behavior. We further extend the analysis to a time-varying threshold Z(t) representing a moving barrier shaped by dynamic epidemiological or policy conditions. In this setting, crossing corresponds to the moment the disease process keeps pace with a shifting target. By linking epidemic dynamics with stochastic first-passage theory, this framework highlights how fluctuations and dynamic thresholds jointly determine the timing of epidemic transitions. The results offer probabilistic tools for anticipating epidemic resurgence, assessing intervention durability, and designing adaptive public health strategies. Applied to a rhinovirus calibration (daily units), our result demonstrates that reducing the per-capita transmission rate effectively suppresses the amplification of stochastic fluctuations and accelerates the transition of the system into a non-epidemic regime. We calibrate the framework, using region-specific parameter estimates for each of the ten U.S. Department of Health and Human Services (HHS) regions over a late-winter to early-summer window, to analyze the weekly percent-positive of rhinovirus/enterovirus (RV/EV) activity in the United States. Our result shows that the modal FPT typically precedes the crest of the percent-positive curve while the mean FPT aligns with the beginning of the sustained decline or plateau.


  • Open Access

    Stochastic modeling and first-passage-time analysis of oncological time metrics with dynamic tumor barriers

    by Olusegun Michael Otunuga

    The first-passage-time (FPT) that a tumor size reaches a particular barrier is important in evaluating the efficacy of anti-cancer therapies and understanding certain oncological time occurrences. For certain verified stochastic models describing the volume of a tumor, a moving barrier for the tumor size in which an explicit solution of an FPT probability density function (PDF) exists for the first time the tumor size reaches the moving barrier is obtained in this work. The stochastic tumor dynamics incorporate anti-cancer therapies/treatments that are administered at varying rates. The first-passage-time density (FPTD) is derived and utilized to determine the time at which the tumor volume first reaches the moving barrier, providing a framework for analyzing various oncological time metrics. These metrics include key time measurements used to characterize tumor progression, evaluate treatment response, and capture recurrence patterns in cancer dynamics. The treatment effort needed to cause reduction in tumor size is also obtained. We obtained, for a tumor growing initially, the FPTD for the random variables describing the first time that the growth of the tumor starts slowing down following the commencement of treatment, the first time that the tumor starts showing signs of shrinkage after the start of treatment, the first time it takes for the reduction in tumor to start slowing down, and the first time for tumor recurrence after partial remission. This work is applied to experimental data including the Murine Lewis Lung Carcinoma cells originally derived from a spontaneous tumor in twenty control mice. The time at which the volume of the tumor of each mouse doubles in size is estimated using the results obtained in this study. Additionally, tumor volume experiments conducted on another eight control mice are used to validate the findings derived in this study.


  • Open Access

    Analysis of the impact of treatments on HIV/AIDS and Tuberculosis co-infected population under random perturbations

    by Olusegun Michael Otunuga

    In this work, we study the impact of treatments at different stages of Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-infection in a population under the influence of random perturbations. This is achieved by constructing a stochastic epidemic model describing the transmission and treatment of the diseases. The model is created with the assumption that transmission rates fluctuate rapidly compared to the evolution of the untreated diseases. The basic reproduction numbers corresponding to the population with HIV infection only (with n stages of infections and treatments), the population with tuberculosis infection only, and the overall population with co-infection (with n stages of infection/treatments) are derived in the presence and absence of noise perturbations. These are used to discuss the long term behavior of the population around a disease-free equilibrium and an endemic equilibrium, and to analyze the effect of noise and treatments on the system. We also showed conditions under which TB infected population dynamic undergoes backward bifurcation and give conditions for disease eradication in the entire population. Analysis shows that small perturbations to the disease-free equilibrium can initially grow under certain conditions, and the introduction of TB treatment is effective in eliminating the co-infection. Numerical simulations are presented for validation of our results using published parameters.


  • Tumor growth and population modeling in a toxicant-stressed random environment

    by Olusegun Michael Otunuga

    When examining some factors that contribute to the growth or decline of a population or tumor, it is essential to consider a random hypothesis. By analyzing the effects of stress on a population (or volume of tumor growth) in a random environment, we develop stochastic models describing the dynamics of the population (or tumor growth) based on random adjustments to the population’s intrinsic growth rate, carrying capacity, and harvesting efforts (or tumor treatments). Apart from the models’ ability to capture fluctuations, the availability of a shape parameter in the models gives it the flexibility to describe a variety of population/tumor data with different shapes. The distribution of the stressed population size with or without harvesting (or treatments) is derived and used to calculate the maximum expected amount of harvests that can be taken from the population without depleting resources in the long run (or the minimum amount of chemotherapy needed to cause shrinkage or eradication of a tumor). The work done is applied to analyze tumor growth using published data comprising of the volume of breast tumor obtained by orthotopically implanting LM2-\(4^{LUC+}\) cells into the right inguinal mammary fat pads of 6- to 8-week-old female Severe Combined Immuno-Deficient mice.


  • Open Access

    Vaccine breakthrough and rebound infections modeling: Analysis for the United States and the ten U.S. HHS regions

    by Olusegun Michael Otunuga, Alexandra Yu

    A vaccine breakthrough infection and a rebound infection cases of COVID-19 are studied and analyzed for the ten U.S. Department of Health and Human Services (HHS) regions and the United States as a nation in this work. An innovative multi-strain susceptible-vaccinated-exposed-asymptomatic-symptomatic-recovered (SVEAIR) epidemic model is developed for this purpose for a population assumed to be susceptible to n-different variants of the disease, and those who are vaccinated and recovered from a specific strain k(k ≤ n) of the disease are immune to present strain and its predecessors j = 1, 2, …, k, but can still be infected by newer emerging strains j = k + 1, k + 2, …, n. The model is used to estimate epidemiological parameters, namely, the latent and infectious periods, the transmission rates, vaccination rates, recovery rates for each of the Delta B.1.617.2, Omicron B.1.1.529, and lineages BA.2, BA.2.12.1, BA.4, BA.5, BA.1.1, BA.4.6, and BA.5.2.6 for the United States and for each of the ten HHS regions. The transmission rate is estimated for both the asymptomatic and symptomatic cases. The effect of vaccines on each strain is analyzed. Condition that guarantees existence of an endemic with certain number of strains is derived and used to describe the endemic state of the population.


  • Analysis and dynamics of measles with control strategies: a mathematical modeling approach

    by Olumuyiwa James Peter, Hasan S. Panigoro, Mahmoud A. Ibrahim, Olusegun Michael Otunuga, Tawakalt Abosede Ayoola, Asimiyu Olalekan Oladapo


  • Stochastic Modeling and Forecasting of Covid-19 Deaths: Analysis for the Fifty States in the United States

    by Olusegun Michael Otunuga, Oluwaseun Otunuga

    In this work, we study and analyze the aggregate death counts of COVID-19 reported by the United States Centers for Disease Control and Prevention (CDC) for the fifty states in the United States. To do this, we derive a stochastic model describing the cumulative number of deaths reported daily by CDC from the first time Covid-19 death is recorded to June 20, 2021 in the United States, and provide a forecast for the death cases. The stochastic model derived in this work performs better than existing deterministic logistic models because it is able to capture irregularities in the sample path of the aggregate death counts. The probability distribution of the aggregate death counts is derived, analyzed, and used to estimate the count’s per capita initial growth rate, carrying capacity, and the expected value for each given day as at the time this research is conducted. Using this distribution, we estimate the expected first passage time when the aggregate death count is slowing down. Our result shows that the expected aggregate death count is slowing down in all states as at the time this analysis is conducted (June 2021). A formula for predicting the end of Covid-19 deaths is derived. The daily expected death count for each states is plotted as a function of time. The probability density function for the current day, together with the forecast and its confidence interval for the next four days, and the root mean square error for our simulation results are estimated.